These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28584251)

  • 1. The 'obesity paradox' may not be a paradox at all.
    Banack HR; Stokes A
    Int J Obes (Lond); 2017 Aug; 41(8):1162-1163. PubMed ID: 28584251
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Obesity paradox' misunderstands the biology of optimal weight throughout the life cycle.
    Dixon JB; Egger GJ; Finkelstein EA; Kral JG; Lambert GW
    Int J Obes (Lond); 2015 Jan; 39(1):82-4. PubMed ID: 24732145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R Study.
    Gaillard R; Steegers EA; Duijts L; Felix JF; Hofman A; Franco OH; Jaddoe VW
    Hypertension; 2014 Apr; 63(4):683-91. PubMed ID: 24379180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
    Elagizi A; Kachur S; Lavie CJ; Carbone S; Pandey A; Ortega FB; Milani RV
    Prog Cardiovasc Dis; 2018; 61(2):142-150. PubMed ID: 29981771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease.
    Antonopoulos AS; Oikonomou EK; Antoniades C; Tousoulis D
    Obes Rev; 2016 Oct; 17(10):989-1000. PubMed ID: 27405510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular mechanisms of obesity paradox.
    Antonopoulos AS; Tousoulis D
    Cardiovasc Res; 2017 Jul; 113(9):1074-1086. PubMed ID: 28549096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and cardiovascular outcomes: a review.
    Ghoorah K; Campbell P; Kent A; Maznyczka A; Kunadian V
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):77-85. PubMed ID: 24526749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor signalings in cardiometabolic diseases.
    Zhang XJ; Zhang P; Li H
    Hypertension; 2015 Aug; 66(2):222-47. PubMed ID: 26077571
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of body mass index with mortality in cardiovascular disease: New insights into the obesity paradox from multiple perspectives.
    Xia JY; Lloyd-Jones DM; Khan SS
    Trends Cardiovasc Med; 2019 May; 29(4):220-225. PubMed ID: 30172579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body fat distribution and cardiovascular risk: a tale of 2 sites.
    Landsberg L
    Arch Intern Med; 2008 Aug; 168(15):1607-8. PubMed ID: 18695073
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial overview: Endocrine and metabolic diseases: Busting BMI: new strategies for the treatment of obesity and metabolic disease.
    Bewick GA
    Curr Opin Pharmacol; 2017 Dec; 37():ix-xii. PubMed ID: 29224800
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the gut in visceral fat inflammation and metabolic disorders.
    Lam YY; Mitchell AJ; Holmes AJ; Denyer GS; Gummesson A; Caterson ID; Hunt NH; Storlien LH
    Obesity (Silver Spring); 2011 Nov; 19(11):2113-20. PubMed ID: 21881620
    [No Abstract]   [Full Text] [Related]  

  • 13. Heart rate recovery is associated with obesity traits and related cardiometabolic risk factors in children and adolescents.
    Laguna M; Aznar S; Lara MT; Lucía A; Ruiz JR
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):995-1001. PubMed ID: 23211756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity paradox in different populations: evidence and controversies.
    Goel K; Lopez-Jimenez F; De Schutter A; Coutinho T; Lavie CJ
    Future Cardiol; 2014 Jan; 10(1):81-91. PubMed ID: 24344665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The obesity paradox].
    Du Pan RC; Golay A
    Rev Med Suisse; 2014 Jun; 10(436):1413-7. PubMed ID: 25055476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effect of adiposity, fat distribution and age on cardiovascular risk factors and motor disability in a cohort of obese women (aged 18-83).
    Lafortuna CL; Agosti F; Proietti M; Adorni F; Sartorio A
    J Endocrinol Invest; 2006 Nov; 29(10):905-12. PubMed ID: 17185900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and prognosis in chronic diseases--impact of cardiorespiratory fitness in the obesity paradox.
    Lavie CJ; Schutter AD; Archer E; McAuley PA; Blair SN
    Curr Sports Med Rep; 2014; 13(4):240-5. PubMed ID: 25014389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrimental and protective fat: body fat distribution and its relation to metabolic disease.
    Booth A; Magnuson A; Foster M
    Horm Mol Biol Clin Investig; 2014 Jan; 17(1):13-27. PubMed ID: 25372727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral fat and insulin resistance - what we know?
    Janochova K; Haluzik M; Buzga M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):19-27. PubMed ID: 30398218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox.
    Bagheri M; Speakman JR; Shemirani F; Djafarian K
    Int J Obes (Lond); 2016 Dec; 40(12):1817-1822. PubMed ID: 27686524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.